Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1437 of 5804
-
New drug aims to supercharge immune system against prostate cancer
Disease control Recruiting nowBackground: Prostate cancer is often treated with radiation and ADT (ADT is androgen deprivation therapy). Up to 30% of these cancers recur within 5 years of treatment. Researchers want to see if a new drug (PDS01ADC) can help the immune system to fight prostate cancer. Objecti…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat pancreatic cancer
Disease control TerminatedThis phase I trial tests the safety, side effects, and best dose of emavusertib (CA-4948) in combination with gemcitabine and nab-paclitaxel in treating patients with pancreatic ductal adenocarcinoma that has spread from where it first started (primary site) to other places in th…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New study checks if filgotinib keeps ulcerative colitis in check Long-Term
Disease control OngoingTo describe the effectiveness, treatment patterns, quality of life, and safety of participants with moderately or severely active UC treated with filgotinib in a real-world setting.
Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New study aims to unlock why Anti-TNF drugs heal some Kids' Crohn's but not others
Disease control Recruiting nowCrohn's disease (CD) is a condition that causes inflammation (swelling, redness) of the lining and wall of the small intestine, large intestine, or both. CD may be associated with abdominal cramps/pain, diarrhea, blood in the stool, weight loss, or delayed growth in children. Whi…
Phase: PHASE4 • Sponsor: Connecticut Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can cleaning up blocks and offering financial help boost Kids' health?
Knowledge-focused OngoingBlack children and adults in the United States fare worse across nearly every health indicator compared to White individuals. In Philadelphia, the location of this study, these health disparities result in a stark longevity gap, with average life expectancies in poor, predominant…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Which ablation method best prevents stroke in atrial fibrillation?
Disease control Recruiting nowAtrial fibrillation (AF) is the cause of 20% of strokes, and the risk of stroke in a person suffering from this arrhythmia increases by 5 times. Ischemic stroke in patients with AF is often fatal and, compared with stroke of other etiology, leads to the most pronounced disability…
Phase: NA • Sponsor: Bakulev Scientific Center of Cardiovascular Surgery • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a structured nursing program boost quality of life in advanced lung cancer?
Symptom relief CompletedSymptom management nursing intervention can improve the self-management efficacy, psychological resilience, and QoL of patients with advanced lung cancer.
Phase: NA • Sponsor: Jie Zeng • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New pill takes aim at Hard-to-Treat blood cancers
Disease control OngoingNon-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose of this study is to assess the safety, pharmacokinetics, and preliminary efficacy of ABBV-101 in adult participants in relapsed or refractor…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hybrid Closed-Loop pump could ease diabetes management
Disease control CompletedTreatment of Type 1 diabetes requires daily insulin therapy given by either multiple daily injections or by continuous infusion via a pump. The insulin dose is calculated taking into consideration blood glucose levels, food intake and activity levels, aiming to avoid high and low…
Sponsor: NHS Lothian • Aim: Disease control
Last updated Jun 26, 2026 17:33 UTC
-
New drug LP-184 tested on tough cancers: hope for Late-Stage patients
Disease control OngoingThe primary objective of this study is to evaluate the safety, tolerability, MTD and RP2D of LP-184 in patients with advanced solid tumors who have relapsed from or are refractory to standard therapy or for whom no standard therapy is available. The secondary objectives are to ch…
Phase: PHASE1, PHASE2 • Sponsor: Lantern Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Glowing dye could replace radioactive tracers in breast cancer surgery
Diagnosis OngoingThis study aims to evaluate the (inter)national implementation of a new diagnostic method for sentinel lymph node (SLN) detection in breast cancer. While Technetium-99m (99mTc) is the current gold standard for SLN detection, it has drawbacks such as limited availability, logistic…
Phase: NA • Sponsor: St. Antonius Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Can Home-Based palliative care ease dementia suffering?
Symptom relief OngoingA multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York C…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New COVID booster for teens shows promise in trial
⭐️ VACCINE ⭐️ CompletedThis is a Phase IIb, open-label, uncontrolled, multi-centre, non-inferiority clinical trial, to assess the safety and immunogenicity of BIMERVAX® as a heterologous booster dose in adolescents. In this study a total of 300 adolescents from 12 to less than 18 years will be enrolle…
Phase: PHASE2 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
New heart surgery tweak may tame dangerous rhythm disorder
Disease control ENROLLING_BY_INVITATIONAtrial fibrillation (AF) is the most common sustained arrhythmia and affects up to 60% of patients undergoing cardiac surgery. Restoring sinus rhythm improves symptoms, reduces stroke risk, and prevents heart failure. Despite guideline recommendations, surgical ablation remains u…
Sponsor: University Paul Sabatier of Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Simple new device could speed up blood infection diagnosis in africa
Diagnosis CompletedDiagnosis of bloodstream infections (BSI) is done by sampling blood in blood culture bottles that are checked for growth in the microbiology laboratory. In LRS, microbiology laboratories are however scarce, and BSI cannot be diagnosed, resulting in overuse of antibiotics which fu…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Pine bark pill tested for long COVID relief in 153 patients
Symptom relief CompletedTo determine the effect of Pycnogenol® versus placebo on patient-reported health status in people with post COVID-19 condition.
Phase: PHASE3 • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo aims to stall rare Cancer's spread
Disease control OngoingThis phase II trial compares the effect of treatment with palbociclib alone to treatment with palbociclib plus cemiplimab for treating patients with dedifferentiated liposarcoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of th…
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New study: does starting this pill sooner save colitis patients from surgery?
Disease control CompletedThe aim of this retrospective observational study is to investigate and compare the real-world effectiveness and safety of upadacitinib when used as first-line exposure versus rescue exposure in patients with acute severe ulcerative colitis (ASUC). The key questions to be addres…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a pill shield hearts from chemo damage? new study investigates
Disease control Recruiting nowThis is a pilot study to evaluate the effects of azeliragon to decrease cardiac toxicity from chemotherapy and the safety of azelirgaon when given with chemotherapy. The Investigators hypothesize that there will be no significant interaction with Azeliragon and chemotherapy and t…
Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a community program cut the time to treat psychosis?
Knowledge-focused Recruiting nowThe First-Episode Psychosis (FPE) is a severe disorder that can include delusions, cognitive disorders and suicidal behavior. In the majority of cases (more than 80%) it evolves into schizophrenia. Numerous studies show that the rapidity of the initial management of FPE would red…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC